Home › Lung Diseases › Michigan
Lung Diseases clinical trials in Michigan
17 studies for Lung Diseases are looking for participants at sites in Michigan.
Cities in Michigan
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Detroit
- Research Site, Royal Oak
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Revival Research Institute, LLC, Dearborn
- Henry Ford St. John Hospital, Grosse Pointe Woods
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- University of Michigan, Ann Arbor
- Henry Ford Hospital, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Revive Research Institute, Inc., Southfield
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245American Lung Association (ALA) Lung Health Cohort
- University of Michigan, Ann Arbor
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Sep 23, 2026 · NCT04543461Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- START Midwest, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- North Ingalls Building, Ann Arbor
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Michigan, Ann Arbor
- The Cancer & Hematology Centers, Grand Rapids
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Michigan, Ann Arbor
- Henry Ford Health, Detroit
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Ann Arbor
- Clinical Research Site, Detroit
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183Deep Functional Phenotyping of the ALA Lung Health Cohort
- University of Michigan, Ann Arbor
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Jul 17, 2026 · NCT06177717Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Karmanos Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 26, 2026 · NCT04614103BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05922761Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761Supporting Evidence-based Responses to Emotional Needs in Emphysema
- Henry Ford Health System, Detroit
Recruiting
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT06600126A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Henry Ford Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Michigan, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 12, 2024 · NCT02735707From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.